Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Science

Trump Administration Unveils First Blueprint for Federal Investment in Science and Tech; Departs from Its Budget Request

President Donald Trump

Washington, DC, August 21, 2017 — Jeffrey Mervis reports in Science that President Donald J. Trump on August 17 translated his campaign promise to “make America great again” into his administration’s first blueprint for federal investment in science and technology.

The White House on issued a four-page memo telling federal agencies that their research dollars should be focused on delivering short-term dividends in strengthening national defense and border security, the economy, and “energy dominance,” as well as improving public health. Continue reading

Opinion: Assemblymen and Stevens President Urge ‘Restore Funding to Turbocharge NJ’s Research and Development’

Trenton, NJ, August 16, 2017Assemblyman Raj Mukherji (D-Hudson), Assemblyman Troy Singleton (D-Burlington) and Dr. Nariman Farvardin, president of Stevens Institute of Technology, write on innovation and Assembly No. 5123 in an op-ed published on August 15 in The Star-Ledger:

One need only to look at the top performers in the S&P 500 — Amazon, Apple, Google parent Alphabet and Facebook — to confirm an indisputable fact about our modern economy: Technological innovation is the key driver of economic growth.

Policymakers who ignore technology’s disruptive impact on markets, industries and jobs do so at their constituents’ peril. (Think Amazon’s impact on the retail industry.) Continue reading

STAT: With Trump in White House, Obama Science Experts Operate Shadow Network to Press Their Positions in Washington

Washington, DC, August 7, 2017 — Lev Facher reports on STAT that nearly all of the Obama administration’s science staff has departed the White House since January, and the Trump administration has moved slowly to replace them.

In the meantime, however, an unofficial shadow office, stocked with Obama loyalists, is quietly at work.

The network, described to STAT by officials from the previous administration who are involved, is informal yet organized, allowing for a far-reaching if largely inconspicuous effort to continue advocating for the Obama science agenda. Continue reading

AAAS CEO Rush Holt Urges U.S. Secretary of State to Name New Science & Technology Adviser

The Hon. Rush Holt

Washington, DC, July 15, 2017 — Secretary of State Rex W. Tillerson must act swiftly to appoint a respected scientist or engineer as his science and technology adviser upon the departure Vaughan Turekian, who has effectively presented the views of the global scientific community and helped incorporate scientific findings into foreign policy considerations, said Rush Holt, the CEO of the American Association for the Advancement of Science (AAAS), in a statement issued July 13.

“We urge Secretary Tillerson to ensure this progress continues by promptly naming a new science and technology adviser as well as to maintain the existing fellowship programs that bring young and established scientists and engineers to contribute to the important work at the State Department,” said Holt, who is a former New Jersey Congressman.   Continue reading

Opinion: Former Merck CEO and Princeton University President Emeritus on ‘Trump’s War on Science Threatens U.S. Prosperity’

Princeton, NJ, July 6, 2017Roy Vagelos, retired Chairman and CEO of Merck & Co. and Chairman of the Board of Regeneron Pharmaceuticals, and Shirley Tilghman, President Emeritus of Princeton University and a professor of Molecular Biology and Public Affairs, published the following opinion piece in The Star-Ledger on June 6:

In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening disease.  New drugs, vaccines, and medical devices have improved human health and increased our lifespan.

In this time, the treatment of cardiovascular disease has been transformed, HIV medications have been developed that mean AIDS is no longer a death sentence, and within the last five years, revolutionary new drugs that work through the activation of the immune system are now successfully treating some forms of cancer. Continue reading

Opinion: Former Merck CEO and Princeton University President Emeritus on ‘Trump’s War on Science Threatens U.S. Prosperity’

Princeton, NJ, June 12, 2017Roy Vagelos, retired Chairman and CEO of Merck & Co. and Chairman of the Board of Regeneron Pharmaceuticals, and Shirley Tilghman, President Emeritus of Princeton University and a professor of Molecular Biology and Public Affairs, published the following opinion piece in The Star-Ledger on June 6:

In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening disease.  New drugs, vaccines, and medical devices have improved human health and increased our lifespan. Continue reading

National Institutes of Health Redirecting Grants to Boost Young Scientists’ Careers, Research

Bethesda, MD, June 12, 2017 — Thomas M. Burton reports in The Wall Street Journal that the National Institutes of Health (NIH) said it would begin redirecting up to about $1.1 billion in research-grant money a year to early- and midcareer scientists to help boost their careers and preserve U.S. science.

The agency said it would begin the redistribution immediately with about $210 million annually, but that the amount would steadily increase over five years to about $1.1 billion a year. Continue reading

85 Percent of Top Science Posts in Trump Administration Have Yet to Be Filled

President Donald Trump

Washington, DC, June 8, 2017 — Chris Mooney reported in The Washington Post that President Donald Trump is facing science-focused problems and issues with a key limitation: lack of staffing.

As of June 6, the Trump White House had announced a nominee for just seven, or 15 percent, of 46 top science posts in the federal government that require Senate confirmation, according to a Post analysis. Continue reading

Trump Proposed 2018 Budget Makes Heavy Cuts to Science Research

President Donald Trump

Washington, DC, June 5, 2017 — Ali Breland reports on The Hill that President Trump’s fiscal 2018 budget unveiled Tuesday proposes massive cuts for the National Science Foundation.

The plan would cut $776 million, an 11 percent reduction, from the foundation, which gives grants for non-medical research in science and engineering.

Mick Mulvaney, the director of the Office of Management and Budget, defended the proposal, accusing the foundation of wasteful spending. Continue reading

House Science Committee Members Urge President Trump to Bolster Scientific Leadership in Administration

Washington, DC, May 19, 2017 — Lev Facher reports on STAT that, in a May 18 letter to the White House, several Democrats on the House Science Committee are scolding President Trump for his belief in fake news stories, tying that belief to the lack of scientific leadership in the White House Office of Science and Technology Policy (OSTP).

“Until the OSTP is adequately staffed and the director position filled by a qualified, objective scientist who understands the difference between alternative news peddled on alt-right websites and legitimate well-vetted scientific facts, we fear that you will continue to be vulnerable to misinformation and fake news,” the lawmakers wrote in the letter. Continue reading